Five bulk drugs likely to be dereserved and delicensed
In a major policy shift, the government is planning to delicense and dereserve five bulk drugs--tetracycline,oxytetracycline, vitamin B1, vitamin B2 and folic acid. At present, these items are
In a major policy shift, the government is planning to delicense and dereserve five bulk drugs--tetracycline,oxytetracycline, vitamin B1, vitamin B2 and folic acid. At present, these items are